Am. J. Respir. Crit. Care Med., Volume 164, Number 4, August 2001, 590-596

The Impact of Aging and Smoking on the Future Burden of Chronic Obstructive Pulmonary Disease
A Model Analysis in the Netherlands

TALITHA L. FEENSTRA, MARIANNE L. L. van GENUGTEN, RUDOLF T. HOOGENVEEN, EMIEL F. WOUTERS, and MAUREEN P. M. H. RUTTEN-van MÖLKEN

National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, The Netherlands; and Department of Pulmonology, University Hospital Maastricht, The Netherlands

Chronic obstructive pulmonary disease (COPD) causes extensive disability, primarily among the elderly. On the World Health Organization ranking list of disability-adjusted life years (DALYs), COPD rises from the twelfth to the fifth place from 1990 to 2020. The purpose of this study is to single out the impact of changes in demography and in smoking behavior on COPD morbidity, mortality, and health care costs. A dynamic multistate life table model was used to compute projections for the Netherlands. Changes in the size and composition of the population cause COPD prevalence to increase from 21/1,000 in 1994 to 33/1,000 in 2015 for men, and from 10/ 1,000 to 23/1,000 for women. Changes in smoking behavior reduce the projected prevalence to 29/1,000 for men, but increase it to 25/ 1,000 for women. Total life years lost increase more than 60%, and DALYs lost increase 75%. Costs rise 90%; smokers cause approximately 90% of these costs. The model demonstrates the unavoidable increase in the burden of COPD, an increase that is larger for women than for men. The major causes of this increase are past smoking behavior and the aging of the population; changes in smoking behavior will have only a small effect in the nearby future.

Keywords: COPD; epidemiology; smoking; costs; model

This article has been cited by other articles:

				R. Nielsen, A. Johannessen, B. Benediktsdottir, T. Gislason, A. S. Buist, A. Gulsvik, S. D. Sullivan, and T. A. Lee Present and future costs of COPD in Iceland and Norway: results from the BOLD study Eur. Respir. J., October 1, 2009; 34(4): 850 - 857. [Abstract] [Full Text] [PDF]

				J. Marin-Corral, J. Minguella, A. L. Ramirez-Sarmiento, S. N. A. Hussain, J. Gea, and E. Barreiro Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients Eur. Respir. J., June 1, 2009; 33(6): 1309 - 1319. [Abstract] [Full Text] [PDF]

				D. Janssen, M. Spruit, E. Wouters, and J. Schols Daily symptom burden in end-stage chronic organ failure: a systematic review Palliative Medicine, December 1, 2008; 22(8): 938 - 948. [Abstract] [PDF]

				S. M. C. Vijgen, P. H. M. van Baal, R. T. Hoogenveen, G. A. de Wit, and T. L. Feenstra Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students Health Educ. Res., April 1, 2008; 23(2): 310 - 318. [Abstract] [Full Text] [PDF]

				M Albers, T Schermer, Y Heijdra, J Molema, R Akkermans, and C van Weel Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease Thorax, March 1, 2008; 63(3): 201 - 207. [Abstract] [Full Text] [PDF]

				F. Blackstock and K. Webster Disease-specific health education for COPD: a systematic review of changes in health outcomes Health Educ. Res., October 1, 2007; 22(5): 703 - 717. [Abstract] [Full Text] [PDF]

				B. R. Celli and P. J. Barnes Exacerbations of chronic obstructive pulmonary disease Eur. Respir. J., June 1, 2007; 29(6): 1224 - 1238. [Abstract] [Full Text] [PDF]

				L. Schirnhofer, B. Lamprecht, W. M. Vollmer, M. J. Allison, M. Studnicka, R. L. Jensen, and A. S. Buist COPD Prevalence in Salzburg, Austria: Results From the Burden of Obstructive Lung Disease (BOLD) Study Chest, January 1, 2007; 131(1): 29 - 36. [Abstract] [Full Text] [PDF]

				M. A.M. Jacobs-van der Bruggen, G. Bos, W. J. Bemelmans, R. T. Hoogenveen, S. M. Vijgen, and C. A. Baan Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk: Results from a modeling study Diabetes Care, January 1, 2007; 30(1): 128 - 134. [Abstract] [Full Text] [PDF]

				C Fuhrman, E Jougla, J Nicolau, D Eilstein, and M-C Delmas Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis Thorax, November 1, 2006; 61(11): 930 - 934. [Abstract] [Full Text] [PDF]

				M. Rutten-van Molken and T. A. Lee Economic Modeling in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, September 1, 2006; 3(7): 630 - 634. [Abstract] [Full Text] [PDF]

				R. J. Halbert, J. L. Natoli, A. Gano, E. Badamgarav, A. S. Buist, and D. M. Mannino Global burden of COPD: systematic review and meta-analysis Eur. Respir. J., September 1, 2006; 28(3): 523 - 532. [Abstract] [Full Text] [PDF]

				S Skumlien, E Haave, L Morland, O Bjortuft, and M S Ryg Gender differences in the performance of activities of daily living among patients with chronic obstructive pulmonary disease Chronic Respiratory Disease, July 1, 2006; 3(3): 141 - 148. [Abstract] [PDF]

				A. D. Lopez, K. Shibuya, C. Rao, C. D. Mathers, A. L. Hansell, L. S. Held, V. Schmid, and S. Buist Chronic obstructive pulmonary disease: current burden and future projections Eur. Respir. J., February 1, 2006; 27(2): 397 - 412. [Full Text] [PDF]

				K. R. Chapman, D. M. Mannino, J. B. Soriano, P. A. Vermeire, A. S. Buist, M. J. Thun, C. Connell, A. Jemal, T. A. Lee, M. Miravitlles, et al. Epidemiology and costs of chronic obstructive pulmonary disease Eur. Respir. J., January 1, 2006; 27(1): 188 - 207. [Full Text] [PDF]

				M. Hoogendoorn, M. P. M. H. Rutten-van Molken, and T. L. Feenstra From the authors Eur. Respir. J., January 1, 2006; 27(1): 241 - 242. [Full Text] [PDF]

				D. Jaffe, Z Eisenbach, Y. Neumark, and O Manor Does one's own and one's spouse's education affect overall and cause-specific mortality in the elderly? Int. J. Epidemiol., December 1, 2005; 34(6): 1409 - 1416. [Abstract] [Full Text] [PDF]

				M. Hoogendoorn, M. P. M. H. Rutten-van Molken, R. T. Hoogenveen, M. L. L. van Genugten, A. S. Buist, E. F. M. Wouters, and T. L. Feenstra A dynamic population model of disease progression in COPD Eur. Respir. J., August 1, 2005; 26(2): 223 - 233. [Abstract] [Full Text] [PDF]

				J. N. Struijs, M. L.L. van Genugten, S. M.A.A. Evers, A. J.H.A. Ament, C. A. Baan, and G. A.M. van den Bos Modeling the Future Burden of Stroke in the Netherlands: Impact of Aging, Smoking, and Hypertension Stroke, August 1, 2005; 36(8): 1648 - 1655. [Abstract] [Full Text] [PDF]

				T. Ringbaek, N. Seersholm, and K. Viskum Standardised mortality rates in females and males with COPD and asthma Eur. Respir. J., May 1, 2005; 25(5): 891 - 895. [Abstract] [Full Text] [PDF]

				R. Buhl and S. G. Farmer Future Directions in the Pharmacologic Therapy of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 83 - 93. [Abstract] [Full Text] [PDF]

				N. Tzanakis, U. Anagnostopoulou, V. Filaditaki, P. Christaki, and N. Siafakas Prevalence of COPD in Greece Chest, March 1, 2004; 125(3): 892 - 900. [Abstract] [Full Text] [PDF]

				J.B. Oostenbrink, M.P.M.H. Rutten-van Molken, M.J. Al, J.A. Van Noord, and W. Vincken One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2004; 23(2): 241 - 249. [Abstract] [Full Text] [PDF]

				The pharmacoepidemiology of COPD: Recent advances and methodological discussion Eur. Respir. J., September 1, 2003; 22(43_suppl): 1s - 44s. [Full Text] [PDF]

				S.T. Weiss, D.L. DeMeo, and D.S. Postma COPD: problems in diagnosis and measurement Eur. Respir. J., June 1, 2003; 21(41_suppl): 4S - 12s. [Abstract] [Full Text] [PDF]

				E Monninkhof, P van der Valk, J van der Palen, C van Herwaarden, M R Partridge, and G Zielhuis Self-management education for patients with chronic obstructive pulmonary disease: a systematic review Thorax, May 1, 2003; 58(5): 394 - 398. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 642 - 662. [Full Text] [PDF]